The aim of the study was to determine the effect of field strain, serotype 7 (FAdV-7 JN-5/10), of fowl adenovirus infection on the replication of Rispens/CVI988 strain of Marek's disease virus. Ninety one-day-old SPF chickens were divided into six groups. The chickens from group I were vaccinated against Marek's disease (MD) and 24 h later infected with the adenovirus; chickens from group II were vaccinated and infected simultaneously; chickens from group III were infected with the adenovirus and 24 h after the infection vaccinated against MD. The chickens from groups IV-VI were: control of infection (IV), control of vaccination (V), and neither vaccinated nor infected (VI). After 3, 7, 14, 21, and 28 d post infection, the number of copies of pp38 gene of Rispens strain and hexon gene of FAdV strain was determined in the bursa of Fabricius and liver using real-time PCR. The results indicated that in all cases the replication of Rispens strain was reduced to about 1.0 log 10 -3.5 log 10 in chickens infected with the adenovirus and vaccinated against MD compared with the chickens only vaccinated. Sixty-three one-day-old SPF chickens infected with adenovirus and vaccinated against MD were challenged with vv MD virus field strain. The protection index in this experiment was 55.6%-77.8%.
Introduction
Marek's disease herpesvirus (MDV) is the aetiological agent of Marek's disease (MD), highly contagious neoplastic disease in chickens (19) . Prophylactic vaccinations are the only way to control MD. For the vaccination, monovalent vaccines, containing FC126 HVT strain, or Rispens/CVI988 strain, and bivalent vaccines, containing both these strains, have been commonly used in chicken flocks. Nowadays, the number of MD cases is increasing. Recently, there are more cases with clinical signs and lesions of MD in spite of chicken vaccinations. Some cases of simultaneous infections with the adenovirus and MDV occur and they became a subject of studies (17) .
The pathogenic role of fowl adenoviruses (FAdV) is not clear. They have high potential as a primary agent of diseases such as inclusion body hepatitis (IBH) (2, 22) , gizzard erosion and ulceration (GEU) (14) , haemorrhagic enteritis (HE) (11) , egg drop syndrome (EDS) (11) , or hydropericardium syndrome (HP) (5, 12) , and can also play an important role in polyaetiological infections (11) . Adenoviral infections can be manifested by mild signs limited to the intestinal or respiratory system (20) . They are also ubiquitous and commonly exist in chickens, which indicate no clinical signs (6, 11) , and can be the reason of the immunosuppression in birds.
The negative effect of fowl adenovirus field strain infection on the replication of herpesvirus strains in chicken embryo fibroblast cultures (CEFs) has been already demonstrated (13) .
The number of cases connected with MD in vaccinated chickens has increased during the last years. Our goal is to investigate and indicate if adenovirus infections, which commonly exist in poultry flocks can be one of the reasons for vaccination failure.
The aim of the study was to determine the effect of adenoviral infection on the replication of Rispens/CVI988 vaccine strain of Marek's disease virus in chickens and its influence on the efficacy of vaccination against MD.
Material and Methods
Chickens. One hundred and fifty-three one-dayold SPF chickens (Lohmann Tierzucht, Germany) were used in the experiment. The trial protocol was approved by the local Ethics Commission.
Experiment design and sample collection Trial I. The chickens were divided into six groups, each consisting of 15 chickens. In group I, chickens were vaccinated against MD with Rispens strain in a dose about 2000 PFU/0.2 mL in right leg i.m. and 24 h later were infected with adenovirus field strain JN-5/10j, which was injected i.m. in left leg in a dose of 10 3.0 TCID 50 /0.2 mL. The chickens from group II were simultaneously vaccinated against MD and infected with the adenovirus strain. Chickens in group III were infected with FAdV-7 strain and 24 h later were vaccinated against MD. Chickens from group IV (control of infection) were infected with FAdV-7 strain. Chickens from group V were vaccinated against MD (control of vaccine). Group VI (control) chickens were neither vaccinated nor infected. The birds were kept in isolated rooms in negatively pressured animal facilities BSL3 and provided with compound feed and water ad libitum. The chickens were observed daily by the monitoring system. After 3, 7, 14, 21, and 28 d after infection, three birds from each group were euthanised. During post mortem examinations, the samples of the bursa of Fabricius and liver were collected. Viral DNA was isolated from animal tissues and real-time PCR was performed.
Trial II. Sixty-three one-day-old chickens were divided into seven equal groups. The chickens were vaccinated against MD and infected with the adenovirus in the same manner as in trial I. The group VII was created as the control of vaccinated and challenged chickens. All chickens of these groups were challenged with MDV strain 31/07 i.m. in left leg in a dose of 10 3.0 TCID 50 /0.2 mL. Detailed trial designs are presented in Table 1 . The experiment was conducted for 12 weeks. All chickens were observed and the postmortem examinations of dead or euthanised birds were done after 12 weeks of the experiment.
Estimation of protection index (PI). The efficiency of the MD vaccine was calculated according to Muleuman's formula: PI = 100 × (% mortality of infected chickens -% mortality of vaccinated and infected chickens)/% mortality of infected chickens.
Adenovirus field strain. Field adenovirus, strain JN-5/10j, was originally isolated from the intestines of seven-week-old chickens vaccinated against MD and showing MD clinical signs. The strain was classified as serotype FAdV-7 and species E. Its titre was 10 4.5 TCID 50 /0.2 mL. Fowl adenovirus reference strain. FAdV reference strain, which represented serotype FAdV-7, belonging to species E, was acquired as freeze-dried from the Charles River Laboratory, USA, and was used as a positive control in real-time PCR.
MDV vaccine strain. MDV commercial vaccine (Mérial, France) containing Rispens/CVI988 strain with the titre of 10 3.6 TCID 50 /0.2 mL has been used for chicken vaccination.
MDV field strain. MDV field strain 31/07 isolated from chickens with clinical signs of MD was classified as very virulent MDV strain (vvMDV).
Sample preparation. The samples of the liver and bursa of Fabricius collected from infected and vaccinated chickens were homogenised, and then frozen and thawed three times, and suspended in 10 mL of Eagle's medium with 10% antibiotic-antimycotic solution (Sigma-Aldrich, Germany). Then, the samples were homogenised and the procedure of thawing and freezing was repeated three times. The homogenates were centrifuged at 14 000 rpm for 15 min. After filtration the supernatants were stored at -20ºC.
DNA extraction. Extraction of viral DNA was performed using DNA Mini Kit (Qiagen, Germany) according to the standard procedure. Whole cellular DNA was extracted directly from homogenates of visceral organs of infected and vaccinated chickens. DNA was also extracted from non-infected CEFs as a negative control. DNA of Rispens/CVI988 strain from commercial vaccine, and DNA from FAdV-7 reference strain served as a positive control. DNA samples were stored at -20°C until the next step of the experiment.
Primer and probe design. Primers for amplification of pp38 gene of Rispens strain and hexon gene of FAdV strain were designed using GenBank database and Primer 3 software. Forward and reverse primers for identification of Rispens strain were created based on the sequences of Rispens strain genome (accession No. AF147806). The sequences were as follows: for pp38 gene of Rispens: pp38-F 5' CCC CAT CTG CTT CAT ACC AT 3', pp38-R 5' GTG ATG GGA AGG CGA TAG AA 3', and the Taqman probe -5' CCA CCG TGA CAG CCA CTC TC 3'. The fluorogenic probe was labelled with reporter: 6-carboxyfluoroscein (FAM) at the 5' end with tetramethylcarboxyrhodamine (TAMRA) as a quencher at 3' end of the sequence. The primers sequences specific for 93 bp fragment of hexon loop L1 FAdV-7 were based on the sequences of FAdV-7 strain hexon gene (GenBank, accession No. AF508955) as follows: FAdV F JSN: 5'AAT GTC ACN ACC GAR AAG GC 3' and FAdV R JSN: 5'CBG CBT RCA TGT ACT GGT A 3'. The primers were synthesised at the Institute of Biochemistry and Biophysics of Polish Academy of Sciences in Warsaw.
Plasmid standards. pPP38 plasmid was constructed by cloning 188 bp fragment of pp38 gene into pGEM-T Easy Vector (Promega, USA) and Blue/White X-Gal/IPTG selection of colonies. The pPP38 was then amplified in E.coli (DH5 ) (Invitrogen, USA) in liquid LB medium with additive of 100 µg/mL ampicillin in 37°C in Max 4000Q apparatus (Barnstead/ Lab-line). Extraction of plasmid DNA was performed from 10 mL of liquid 18 h culture of E.coli (DH5 ) cells using Plasmid Maxi Kit (Qiagen, Germany).
The pHexon plasmid was constructed by cloning of 93 bp fragment gene into pSTBlue-1 AccepTor TM Vector Giga Kits (Novagen, Germany) and Blue/White X-Gal/IPTG selection of colonies with the same procedure as above.
Real-time PCR for the identification of pp38 and hexon genes. Reaction for pPP38 gene was conducted using QuantiTect PCR Probe kit (Qiagen) in the 7500 real -time PCR System (Applied Biosystems, USA). The final volume of the master mix was 20 µL and contained: 10.
For the identification of hexon gene QuantiTect, PCR Probe (Qiagen) was used. The final volume of the master mix was 25 µL and it contained: 12.5 µL of 2x QuantiTect Probe PCR Master Mix (SybrGreen included), 1 µL of 0.4 µM each primer for hexon gene of FAdV-7 strain FAdVF JSN and FAdVR JSNR, and 8.5 µL of deionised water.
The conditions for the identification of pp38 gene were as follows: 50°C for 2 min, 95°C for 15 min: 40 cycles-94°C for 15 s, and 60°C for 1 min. The conditions for the identification of hexon gene were as follows: 50°C for 2 min, 95°C for 15 min, 40 cycles-94°C for 15 s, and 55°C for 1 min.
Quantification of pp38 and hexon genes copy number. Real-time PCR was conducted to quantify the exact number of copies of pp38 and hexon genes using standard curve in Applied Biosystems software (Version 2.0.1). Quantification of the viral copy number was performed according to the procedure previously described (1). On the basis of serial ten-fold dilutions of pPP38 from 10 2.0 to 10 5.0 DNA copies/1 µL, four point standard curves were prepared and used for calculation of the number of pp38 MDV gene copies. The serial ten-fold dilutions of pHexon from 10 2.0 to10 7.0 DNA copies/2 µL were prepared. On this basis, five point standard curves were prepared and used for hexon FAdV calculations. The fluorescent curves indicated the amplification of fragments specific for the examined genes.
Results
Trial I. During the trial I, no clinical signs of infection and mortality in chickens were observed. The copy number of pp38 gene of Rispens strain and hexon gene of FAdV-7 strain, determined in the bursa of Fabricius and liver in chickens from groups I, II, and III (independent neither from the time of infection nor vaccination), were lower than the number of copies found in chickens from group V (Fig. 1) , which were only vaccinated. The average difference between groups on 21 d of the trial was about 3.5 log 10 . The copy number of pp38 gene of Rispens strain calculated in the liver from 7 till 28 d of the trial was lower in vaccinated and infected chickens compared with the results obtained in chickens only vaccinated (group V) (Fig. 2) . The highest number of copies was obtained on day 14 of the trial and was equal to 10 6.0 compared with the chickens from group V, in which the copy number was about 10 7.0 . After 14 d, the copy number decreased to about 10 2.5-3.0 but was still lower compared with the chickens in group V (about 10 3.5 to 10 4.0 ). The copy number of hexon gene of FAdV-7 strain was also determined in the bursa of Fabricius (Fig. 3) . From day seven to day 14 of trial, it was on similar level in chickens which were vaccinated and infected, and was about 10 4.0 to 10 5.0 copies, and even higher than the number of copies of hexon gene in the bursa of Fabricius in chickens from group IV (only infected). The copy number was slowly decreasing on day 21 in the liver in chickens from group III, and was estimated on the level of about 10 4.0 , but in groups I and II the copy number was about 10 4.0 to 10 4.5 when compared with chickens in group IV, in which the copy number was around 10 3.5 . On day 28 of the experiment, the copy number of hexon gene was higher in chickens in groups I and II, and was around 10 5.0 (Fig. 4) . The highest copy number of the hexon gene in the liver was obtained on day 28 of the trial and was higher in groups I, II, and III compared with chickens of group IV.
Trial II. The results of the experiment are presented in Table 1 . In group I, three chickens were crouching and indicated the symptoms of asymmetric paralysis of one limb. They died in the ninth, 10 th and 11 th week. During post mortem examinations, enlarged spleen and liver with necrotic changes were observed. In gizzards, callus was noted. In group II, two chickens died and enlarged liver was noted between the 16 th and 20 th d. Spleens were small and involution of the bursa of Fabricius and thymus were observed. Four chickens from group III died between 16 th and 20 th d, and necrotic changes on the surface of the liver and spleen, and involution of the bursa of Fabricius and thymus were demonstrated. On the 10 th d of the experiment, chickens of groups IV and V were gathering near the source of light, and were not interested in feed and water. Mortality in these groups was 100%. Similar changes in their organs to those observed in chickens from groups I-III were noted, and they were typical for Marek's disease. Chickens from groups VI and VII did not reveal any clinical symptoms of infection.
The protection index of vaccine was estimated for group I at 66.67%, for group II at 77.78%, and for group III at 55.6%, compared to the group VII (control of vaccine) in which the index was 100%. 
Discussion
Okuda et al. (14) indicated that some FAdV strains have the tropism to digestive organs and pancreas rather than to the liver. In the study, the presence of FAdV-7 strain in the bursa Fabricius and liver of infected chickens was demonstrated. Immunosuppression in broiler chickens associated with hydropericardium syndrome (HP) has been studied (21) . A significant decrease in the percentage of IgM producing B cells in the bursa of Fabricius of chickens infected with serotype FAdV-4, and decreased bursal index was observed in this study. Virulent FAdV strains have the tropism to lymphoid tissues and lymphocytes, which can cause humoral and cellular disturbances in immunocompetency (7) . In recent years, adenoviruses have been recognised as pathogens causing morbidity and mortality among immunocompromised patients with liver transplant, pediatric transplant and patients that received lymphocyte antibodies (8) . The presence of DNA of adenovirus species C in T lymphocytes was determined in the tonsils of hospitalised patients, and it was much higher in younger persons (3) .
Pathogenic course of adenovirus infection can be also induced by co-infection with another virus, or previous immunosuppression as presented in studies on FAdV and chicken anaemia virus (CAV) co-infection (23) . The immunosuppressive influence of FAdVs has been observed in birds infected with virulent FAdV-8 strain (16) . A correlation between a simultaneous adenovirus and herpesvirus infections and disease development was observed by Lappalainen et al. (10) . Simultaneous infections and immunosuppressive effect of canine distemper virus (CDV) were implicated with the co-infection with canine adenovirus-2 (CAV-2), resulting in several pulmonary lesions that lead to pneumonia and hepatocellular necrosis (4) .
Studies by Jeurissen et al. (9) demonstrated the influence of CAV on the pathogenesis of Marek's disease in experimentally infected chickens. The influence of CAV depended on the dose of MDV. CAV is able to suppress the immune response and replication of MDV when the high doses of MDV are used. CAV infection can be associated with the failure of vaccinations against MD (9) . It was found that CAV influences the humoral immune response in chickens after the vaccination with HVT (15). The results obtained by Salamonowicz et al. (18) revealed that reovirus infection caused lower antibodies production and decreased efficiency of the Marek's disease vaccine in chickens vaccinated against MD. Lower replication of HVT strain during the in vivo coinfection with reovirus strain was also determined. It was shown that the protection index for MD vaccine during the co-infection with reovirus in chickens was about 83.3%.
The in vitro study on the interactions between FAdV-7 and turkey herpesvirus FC126 on CEFs indicated that the FAdV lowered the replication of the herpesvirus (13) , and probably influenced the effectiveness of vaccination.
The experiments showed that adenovirus field strain isolated from birds increased the replication of Rispens strain in infected and vaccinated chickens and decreased protective properties of MD vaccine. The obtained results indicated that FAdV strains, which commonly exist in poultry flocks can be one of the cause of decreased efficiency of the Marek's disease vaccine.
